Excessive visceral fat study
This study seems to be close to being concluded as some centres have "completed" and some starting the recruitment as per the recent update
yesterday.
The purpose of it is among others to establish the relation between excessive visceral fat(not general obesity) and cardiovascular diseases in PLWH on various antivirals. It's a observational study so if the results clearly show a direct correlation between visceral and ectopic fat and serious co morbidities(heart diseases) it would be a useful tool to boost Egrifta's sales which reduces visceral fat. It is commonly known that obesity in both general population and subgroups such as HIV patients are linked to various common diseases but establishing a proven correlation between the real issue (the more problematic and more metabolic active visceral fat) to various serious conditions in subgroups such as PLWH is less acknowledged/understood by both doctors and their patients. The point is the purpose of this study and other ongoing studies about the problematic deeply stored fat, peripheral nerve damages, cognitive impairment etc. and the beneficial impact of Tesamorelin on those conditions some already proven others still under investigation is to increase the therapeutic potentials and value of the drug in various conditions each effecting patients who could benefit from additional treatment options.
History of Changes for Study: NCT05383456